» Articles » PMID: 25332855

A Comprehensive Review of Urologic Complications in Patients with Diabetes

Overview
Journal Springerplus
Date 2014 Oct 22
PMID 25332855
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes Mellitus (DM) is a chronic disease characterized by hyperglycemia, as a result of abnormal insulin production, insulin function, or both. DM is associated with systemic complications, such as infections, neuropathy and angiopathy, which involve the genitourinary tract. The three most significant urologic complications include: bladder cystopathy, sexual dysfunction and urinary tract infections. Almost half of the patients with DM have bladder dysfunction or cystopathy, which can be manifested in women as hypersensitivity (in 39-61% of the diabetic women) or neurogenic bladder. In males it can be experienced as lower urinary tract symptoms (in 25% of diabetic males with a nearly twofold increased risk when seen by age groups). Additionally, an increased prostate volume affects their micturition as well as their urinary tract. Involving sexual dysfunction in women, it includes reduced libido, decreased arousal, clitoral erectile dysfunction and painful or non-sensitive intercourse; and in diabetic males it varies from low libido, ejaculatory abnormalities and erectile dysfunction. Globally, sexual disorders have a prevalence of 18-42%. Erectile dysfunction is ranked as the third most important complication of DM. Urinary tract infections are observed frequently in diabetic patients, and vary from emphysematous infections, Fournier gangrene, staghorn infected lithiasis to repetitive bacterial cystitis. The most frequent finding in diabetic women has been lower urinary tract infections. Because of the high incidence of obesity worldwide and its association with diabetes, it is very important to keep in mind the urologic complication associated with DM in patients, in order to better diagnose and treat this population.

Citing Articles

A Brief Overview of Cholinergic and Phosphodiesterase-5 Inhibitors in Diabetic Bladder Dysfunction.

Kallinikas G, Haronis G, Kallinika E, Kozyrakis D, Rodinos E, Filios A Int J Mol Sci. 2024; 25(19).

PMID: 39409033 PMC: 11476953. DOI: 10.3390/ijms251910704.


Male Akita diabetic mice develop underactive bladder independent of NLRP3 that can be prevented with blood glucose control.

Livingston A, Purves J, Odom M, Jin H, Hughes Jr F Continence (Amst). 2024; 12.

PMID: 39399064 PMC: 11466384. DOI: 10.1016/j.cont.2024.101690.


Metformin modulates the TXNIP-NLRP3-GSDMD pathway to improve diabetic bladder dysfunction.

Huang B, Zhang J, Tian H, Ren S, Chen K, Feng J Sci Rep. 2024; 14(1):23868.

PMID: 39396086 PMC: 11470931. DOI: 10.1038/s41598-024-72129-0.


Methylglyoxal and Advanced Glycation End Products (AGEs): Targets for the Prevention and Treatment of Diabetes-Associated Bladder Dysfunction?.

Oliveira A, de Oliveira M, Monica F, Antunes E Biomedicines. 2024; 12(5).

PMID: 38790901 PMC: 11118115. DOI: 10.3390/biomedicines12050939.


Concomitant Use of Sodium-Glucose Cotransporter 2 Inhibitors and Overactive Bladder Drugs and the Risk of Urinary Tract Infection.

Bea S, Lee H, Park S, Cho Y, Choi W, Bykov K Clin Pharmacol Ther. 2024; 115(5):1132-1140.

PMID: 38284421 PMC: 11023771. DOI: 10.1002/cpt.3182.


References
1.
Ikeda K, Wada Y, Foster Jr H, Wang Z, Weiss R, Latifpour J . Experimental diabetes-induced regression of the rat prostate is associated with an increased expression of transforming growth factor-beta. J Urol. 2000; 164(1):180-5. View

2.
Owiredu W, Amidu N, Alidu H, Sarpong C, Gyasi-Sarpong C . Determinants of sexual dysfunction among clinically diagnosed diabetic patients. Reprod Biol Endocrinol. 2011; 9:70. PMC: 3118328. DOI: 10.1186/1477-7827-9-70. View

3.
Gray M, Wang C, Sacks M, Yoshimura N, Chancellor M, Nagatomi J . Time-dependent alterations of select genes in streptozotocin-induced diabetic rat bladder. Urology. 2008; 71(6):1214-9. DOI: 10.1016/j.urology.2007.11.054. View

4.
Daneshgari F, Liu G, Birder L, Hanna-Mitchell A, Chacko S . Diabetic bladder dysfunction: current translational knowledge. J Urol. 2009; 182(6 Suppl):S18-26. PMC: 4684267. DOI: 10.1016/j.juro.2009.08.070. View

5.
Enzlin P, Mathieu C, Van den Bruel A, Bosteels J, Vanderschueren D, Demyttenaere K . Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care. 2002; 25(4):672-7. DOI: 10.2337/diacare.25.4.672. View